Inventor · disambiguated record
Hugh Y. Rienhoff, Jr.
Also filed as: RIENHOFF HUGH · RIENHOFF HUGH Y · RIENHOFF HUGH Y JR · RIENHOFF JR HUGH Y
15 granted patents·17 pending applications·77 citations·filing 2001–2023
92Inventor score
Top patents by PatentIndex Score
32 records- 0195US10519118B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2018·Granted Dec 31, 2019·8 cites·22 claims
- 0294US10882835B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 5, 2021·6 cites·14 claims
- 0393US11230534B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Jan 25, 2022·4 cites·10 claims
- 0493US9981922B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2016·Granted May 29, 2018·11 cites·9 claims
- 0592US8063227B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2009·Granted Nov 22, 2011·23 cites·1 claims
- 0690US10370346B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2017·Granted Aug 6, 2019·7 cites·48 claims
- 0790US9790195B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2014·Granted Oct 17, 2017·10 cites·58 claims
- 0888US11655226B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2020·Granted May 23, 2023·1 cites·19 claims
- 0984US11578059B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2019·Granted Feb 14, 2023·2 cites·30 claims
- 1077US11773068B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2021·Granted Oct 3, 2023·0 cites·5 claims
- 1176US11932629B2KDM1A inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2022·Granted Mar 19, 2024·0 cites·21 claims
- 1272US8846731B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Sep 30, 2014·1 cites·7 claims
- 1371US8829197B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Sep 9, 2014·1 cites·3 claims
- 1471US8710087B2Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agentsTAPPER AMY E·Filed 2011·Granted Apr 29, 2014·1 cites·6 claims
- 1569US8993606B2Oral formulations for treating metal overloadFERROKIN BIOSCIENCES INC·Filed 2012·Granted Mar 31, 2015·2 cites·10 claims
- 1666US2023000835A1Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1764US2025288668A1Methods for the enhancement of therapeutic effect of car-t cellsIMAGO BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1863US2005089905A1Polymorphisms associated with ion-channel diseaseFiled 2004·Application pending·0 cites
- 1962US2021196711A1Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2062US2021386733A1Lysine-specific histone demethylase inhibitors for the treatment of myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2161US2025032454A1Kdm1a inhibitors for the treatment of diseaseIMAGO BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2256US2019070172A1Lysine-specific histone demethylase as a novel therapeutic target in myeloproliferative neoplasmsIMAGO BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 2356US2003162192A1Polymorphisms associated with ion-channel diseaseFiled 2002·Application pending·0 cites
- 2454US2002133495A1Database system and methodFiled 2001·Application pending·0 cites
- 2554US2003208454A1Method and system for populating a database for further medical characterizationFiled 2001·Application pending·0 cites
- 2653US2002019746A1Aggregating persons with a select profile for further medical characterizationFiled 2001·Application pending·0 cites
- 2752US2002010552A1System for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area networkFiled 2001·Application pending·0 cites
- 2852US2002049772A1Computer program product for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area networkFiled 2001·Application pending·0 cites
- 2945US2001049102A1Methods for determining single nucleotide variationsFiled 2001·Application pending·0 cites
- 3045US2013005781A1Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agentsFERROKIN BIOSCIENCES INC·Filed 2012·Application pending·0 cites
- 3145US2015299151A1Polymorph forms of desazadesferrithiocin analogsFEEROKIN BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 3240US2011053993A1Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agentsFERROKIN BIOSCIENCES INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →